The report said, ‘The prequalification of the world’s second malaria vaccine, developed by Oxford University and manufactured by the Serum Institute of India, is poised to expand access to ...

so this second vaccine is a vital additional tool to protect more children faster, and to bring us closer to our vision of a malaria-free future". At least 28 African countries plan to introduce ...

The vaccine has been developed by the University of Oxford and is only the second malaria vaccine to be developed. Malaria kills mostly babies and infants, and has been one of the biggest scourges ...

Scientists at La Trobe University have discovered a new antibody-like molecule that could be used in therapy to prevent ...

[VOA] The World Health Organization on Monday announced the recommendation of a second malaria vaccine, with the aim of giving countries a cheaper and more readily available option to tackle the ...

Vaccine efficacy against infection with malaria parasites in the lower dose group was as high or higher during the second year (61%) as during the first year, without boosting, a first for a ...

A recent study published in the journal Nature Reviews Microbiology reviewed malaria vaccines and their successes and failures. Nearly half of the world’s population is at risk of malaria ...

Vaccine efficacy against infection with malaria parasites in the lower dose group was as high or higher during the second year (61%) as during the first year, without boosting, a first for a ...

Malaria, a longstanding and life-threatening disease, contributes to approximately 249 million global cases.1 Plasmodium ...

Medscape Medical News, February 06, 2024 Second Malaria Vaccine Highly Protective, Trial Results Show A malaria vaccine developed by the University of Oxford and the Serum Institute of India ...

Malaria continues to be a leading cause of illness and death in South Sudan, particularly among young children. In 2022, the country reported an estimated 2.8 million cases and 6,680 deaths. About ...